Mangaluru stares at worst water crisis

Newsroom, June 14: Bollywood star Sushant Singh Rajput, who was found dead in his house in Mumbai’s Bandra today, was heartbroken after the death of his former manager Disha Salian.

34-year-old actor had posted a heartfelt note after her death: “It’s such devastating news. My deepest condolences to Disha’s family and friends. May your soul rest in peace.” 

The police are considering 28-year-old Disha’s death as an accidental one and the investigation is on to find if it was a suicide. She died after falling off the 14th floor of a building in Malad, Mumbai on June 8.

It is not yet known if there is any connection between the two deaths. Sushant’s house help reportedly found him hanging inside his room on Sunday and cops are investigating the case. He was recently seen in Nitesh Tiwari’s Chhichhore and more recently on Netflix opposite Jacqueline Fernandez in Drive.

Who is Disha Salian?

Disha Salian hails from Karnataka’s coastal district of Udupi. She was born in 1992 into a business family background. She reportedly migrated to Mumbai with her family at an early age. 

After completing her education, she worked in the Times of India Group for more than three years. The she went on the become the celebrity manager at Media Vantage.

Apart from Sushant, she had great links with many popular celebrities like Bharti Singh, Alisha Panwar, and others.

Hubballi, Jan 29: Thousands of people took part in a protest march against the Citizenship (Amendment) Act (CAA) causing traffic snarl in the city on Tuesday.

Various Dalit organisations had taken part in protest organised under the aegis of the 'Samvidana Samrakshana Samiti'.

KPCC members including MLA Prasad Abbayya, former Minister A.M. Hindasageri and office-bearers also joined the protest.

They congregated first at B.R. Ambedkar Statue near the Head Post Office in Hubballi. Holding flags and banners, the protesters marched from Ambedkar statue to mini Vidhana Soudha covering Lamington Road, Sangolli Rayanna Statue and Kittur Chennamma Circle.

Mr. Abbayya said that despite opposition from various minority communities and progressive organisations, the Union government had not changed its stand. The opposition would continue till the new law was repealed, he said.

He termed the CAA as a draconian law that meted out injustice to not only Muslims but also to Hindus. “Giving citizenship based on documents is highly condemnable. At a time when the country is undergoing an economic slowdown, it is highly condemnable that thousands of crores are being spent to enact the law. The Union government should immediately abolish the new law,” he said.

They submitted a memorandum to the Hubballi tahsildar that was addressed to the President, seeking abolition of the new law. In view of the march, the police had diverted traffic and had made elaborate bandobast.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.